Search Medical Condition
Please enter condition
Please choose location from dropdown

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (238) clinical trials

A Prospective, vehicle-controlled, double blind, multicenter, randomized phase II study of B244 delivered as a topical spray to determine safety in subjects with mild to moderate atopic dermatitis.

Phase N/A

Healthy Volunteers Needed for an Investigational Vaccine Study A clinical research study to evaluate an investigational vaccine against infections caused by Streptococcus pneumoniae is now accepting study volunteers. Streptococcus pneumoniae is one of the leading causes of bacteremia (S. pneumoniae in the blood), bacterial meningitis, pneumonia, and middle ear infections ...

Phase

Participants with atopic dermatitis and eczema conditions will be given a lotion to use over the course of 4 weeks. They will be asked to return to the clinic at weeks 2 and 4 where assessments will be done to see how effective the lotion is.

Phase N/A

A randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability and immunologic effects of HAL-MPE1 subcutaneous immunotherapy in adult and pediatric subjects with peanut allergy.

Phase

Children and adolescents with HDM allergic asthma are asked to participate in a research study being conducted by Cohen Children's Medical Center of New York.

Phase N/A

The primary objective for part A of the study is to characterize the safety and pharmacokinetics (PK) of dupilumab administered as a single dose in pediatric patients, 6 months to less than 6 years of age with severe atopic dermatitis (AD). The primary objective for part B of the study ...

Phase

Have you had moderate to severe atopic dermatitis for at least 1 year? A clinical trial designed to evaluate the safety and effectiveness of a new investigational medication under development for adult patients with moderate-to-severe atopic dermatitis is currently being conducted. All subjects will receive injections of trial medication every ...

Phase N/A

The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.

Phase

A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of an injectable medication, tralokinumab, in combination with topical corticosteroids in subjects with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

Phase

Now enrolling ages 18 and older for moderate to severe atopic dermatitis.

Phase N/A